Lockheed Martin, Northrop Grumman, and RTX are positioned well in 2026 with strong backlogs and rising defense budgets, especially for munitions. Lockheed Martin benefits from a $194 billion backlog and multi-year contracts boosting production, despite some execution risks. Northrop Grumman's B-21 program shifts from loss to profit, with record backlog and expanded production capacity, though cash flow timing remains a concern. RTX stands out with the largest, most diversified backlog and raised 2026 guidance, supported by growth across its segments, but faces operational and regulatory challenges. The sector outlook is positive with $60 billion allocated for munitions in the FY 2027 budget, focusing on execution to lead the market.
Small-cap stocks in the U.S. market continue to be the most undervalued segment, even after their best first-half performance in over 30 years, according to Morningstar's Q3 2026 outlook. The overall market shows a modest 8% discount to fair value, b...
Xanadu Quantum Technologies and Lockheed Martin have launched a collaboration to enhance quantum computing skills among Lockheed Martin engineers through the Quantum Talent Pipeline (QTP) program. This initiative uses Xanadu's PennyLane platform and ...
Lockheed Martin reaffirmed its 2026 financial guidance with expected sales of $77.5–$80 billion, EPS of $29.35–$30.25, and free cash flow of $6.5–$6.8 billion, anticipating margin improvements in the second half of the year. The company faces near-te...
